단백질 정제 및 분리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 기술별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Protein Purification And Isolation Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,374,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,782,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,597,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

단백질 정제 및 분리 시장 개요

세계 단백질 정제 및 분리 시장 규모는 2024년에 104억 4,000만 달러로 평가되었습니다. 2033년에는 259억 6,000만 달러에 달하고, 2025-2033년10.77%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이러한 성장의 배경에는 바이오의약품 수요 증가, 정제 기술의 발전, 단백질체학 및 의약품 개발 연구 증가가 있습니다.

혈장 바이오마커 연구: 단백질 정제 및 분리 시장 확대의 촉매제

종양학 및 정밀의료 분야에서 혈장 바이오마커에 대한 관심이 높아지면서 세계 단백질 정제 및 분리 시장의 중요한 성장 동력으로 부상하고 있습니다. 혈장 바이오마커(질병 상태를 반영하는 혈액 내 순환하는 단백질)는 특히 암의 조기 진단, 예후 예측, 치료 반응 모니터링에 매우 중요한 역할을 하고 있습니다. 이러한 단백질을 확인하기 위해서는 혈장과 같은 복잡한 생물학적 시료에서 미량 수준의 단백질을 분리할 수 있는 고감도 정밀 정제 기술이 필요합니다. 바이오마커를 이용한 진단에 대한 수요가 증가함에 따라 크로마토그래피, 전기영동, 마그네틱 비드 기반 플랫폼 등 효율적이고 확장 가능한 단백질 정제 시스템의 필요성도 증가하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

• 시장 계보
  • 상위 시장 분석
  • 보조 시장 분석
• 단백질 정제 및 분리 시장 - 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 시장 분석 툴
  • Porter의 Five Forces 분석
  • PESTLE 분석
  • COVID-19의 영향 분석

제4장 단백질 정제 및 분리 시장 : 제품 비즈니스 분석

• 제품 부문 대시보드
• 세계의 단백질 정제 및 분리 시장 제품 변동 분석, 2024년과 2033년
• 세계의 단백질 정제 및 분리 시장 규모와 동향 분석(제품별, 2021-2033년)
• 기기
• 소모품

제5장 단백질 정제 및 분리 시장 : 기술 비즈니스 분석

• 기술 부문 대시보드
• 세계의 단백질 정제 및 분리 시장 기술 변동 분석, 2024년과 2033년
• 세계의 단백질 정제 및 분리 시장 규모와 동향 분석(기술별, 2021-2033년)
• 한외여과
• 강수량
• 크로마토그래피
• 전기영동
• 웨스턴 블로팅
• 기타

제6장 단백질 정제 및 분리 시장 : 용도 비즈니스 분석

• 용도 부문 대시보드
• 세계의 단백질 정제 및 분리 시장 용도 변동 분석, 2024년과 2033년
• 세계의 단백질 정제 및 분리 시장 규모와 동향 분석(용도별, 2021-2033년)
• 바이오마커 발견
• 약제 검사
• 진단
• 단백질간 상호작용 연구

제7장 단백질 정제 및 분리 시장 : 최종 용도 비즈니스 분석

• 최종 용도 부문 대시보드
• 세계의 단백질 정제 및 분리 시장 최종 용도 변동 분석, 2024년과 2033년
• 세계의 단백질 정제 및 분리 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
• 제약 바이오테크놀러지 기업
• 병원
• 학술연구기관
• CRO

제8장 단백질 정제 및 분리 시장 : 제품, 기술, 용도, 최종 용도에 의한 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2033년
• 지역별 시장 대시보드
• 시장 규모, 예측, 동향 분석, 2021-2033년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 콜롬비아
  • 페루
  • 칠레
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 기업/경쟁 분류
• 전략 매핑
• 기업 시장 현황 분석, 2024년
• 기업 개요/상장기업
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Cube BIoTech GmbH
  • Promega Corporation
  • Norgen BIoTek Corp.
  • Takara Bio. Inc.
  • Danaher

LSH

영문 목차

영문목차

Protein Purification And Isolation Market Summary

The global protein purification and isolation market size was estimated at USD 10.44 billion in 2024 and is projected to reach USD 25.96 billion by 2033, growing at a CAGR of 10.77% from 2025 to 2033. This growth is driven by increasing demand for biopharmaceuticals, advancements in purification technologies, and rising research in proteomics and drug development.

Plasma Biomarker Research: A Catalyst for Protein Purification and Isolation Market Expansion

The rising focus on plasma biomarkers in oncology and precision medicine is emerging as a significant growth driver in the global protein purification and isolation market. Plasma biomarkers-proteins circulating in the blood that reflect disease states-play a pivotal role in early diagnosis, prognosis, and monitoring of therapeutic responses, particularly in cancer. Identifying these proteins requires highly sensitive and precise purification technologies capable of isolating trace-level proteins from complex biological samples like plasma. As demand for biomarker-based diagnostics increases, so does the need for efficient and scalable protein purification systems, including chromatography, electrophoresis, and magnetic bead-based platforms.

Global Protein Purification And Isolation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and analyzes the latest industry trends in each sub-segment from 2021 to 2033. Grand View Research has segmented the global protein purification and isolation market report based on product, technology, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Consumables
  • Kits
  • Reagents
  • Columns
  • Magnetic Beads
  • Resins
  • Others
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Ultrafiltration
• Precipitation
• Chromatography
  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Reversed Phase Chromatography
  • Size Exclusion Chromatography
  • Hydrophobic Interaction Chromatography
• Electrophoresis
  • Gel Electrophoresis
  • Isoelectric Focusing
  • Capillary Electrophoresis
• Western Blotting
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug Screening
• Biomarker Discovery
• Protein-Protein Interaction Studies
• Diagnostics
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic And Research Institutes
• Hospitals
• Pharmaceutical And Biotechnology Companies
• CROs
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
  • Colombia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Protein Purification and Isolation Market- Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTLE Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Protein Purification and Isolation Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Protein Purification and Isolation Market Product Movement Analysis, 2024 & 2033
• 4.3. Global Protein Purification and Isolation Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Instrument
  • 4.4.1. Global Instrument Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Global Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Kits
    • 4.5.2.1. Global Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Reagents
    • 4.5.3.1. Global Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Columns
    • 4.5.4.1. Global Columns Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Magnetic Beads
    • 4.5.5.1. Global Magnetic Beads Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.6. Resins
    • 4.5.6.1. Global Resins Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.7. Others
    • 4.5.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Protein Purification and Isolation Market: Technology Business Analysis

• 5.1. Technology Segment Dashboard
• 5.2. Global Protein Purification and Isolation Market Technology Movement Analysis, 2024 & 2033
• 5.3. Global Protein Purification and Isolation Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 5.4. Ultrafiltration
  • 5.4.1. Global Ultrafiltration Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.5. Precipitation
  • 5.5.1. Global Precipitation Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.6. Chromatography
  • 5.6.1. Global Chromatography Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Ion Exchange Chromatography
    • 5.6.2.1. Global Ion Exchange Chromatography Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Affinity Chromatography
    • 5.6.3.1. Global Affinity Chromatography Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. Reversed Phase Chromatography
    • 5.6.4.1. Global Reversed Phase Chromatography Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6.5. Size Exclusion Chromatography
    • 5.6.5.1. Global Size Exclusion Chromatography Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6.6. Hydrophobic Interaction Chromatography
    • 5.6.6.1. Global Hydrophobic Interaction Chromatography Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.7. Electrophoresis
  • 5.7.1. Global Electrophoresis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Gel Electrophoresis
    • 5.7.2.1. Global Gel Electrophoresis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. Isoelectric Focusing
    • 5.7.3.1. Global Isoelectric Focusing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.7.4. Capillary Electrophoresis
    • 5.7.4.1. Global Capillary Electrophoresis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.8. Western Blotting
  • 5.8.1. Global Western Blotting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Protein Purification and Isolation Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Protein Purification and Isolation Market Application Movement Analysis, 2024 & 2033
• 6.3. Global Protein Purification and Isolation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Biomarker Discovery
  • 6.4.1. Global Biomarker Discovery Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 6.5. Drug Screening
  • 6.5.1. Global Drug Screening Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 6.6. Diagnostics
  • 6.6.1. Global Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 6.7. Protein-Protein Interaction Studies
  • 6.7.1. Global Protein-Protein Interaction Studies Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Protein Purification and Isolation Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Protein Purification and Isolation Market End Use Movement Analysis, 2024 & 2033
• 7.3. Global Protein Purification and Isolation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.5. Hospitals
  • 7.5.1. Global Hospitals Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.6. Academic and Research Institutions
  • 7.6.1. Global Academic and Research Institutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.7. CROs
  • 7.7.1. Global CROs Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Protein Purification and Isolation Market: Regional Estimates & Trend Analysis by Product, Technology, Application, and End Use

• 8.1. Regional Market Share Analysis, 2024 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts, Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.4. Columbia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Columbia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.5. Peru
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Peru market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.6. Chile
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Technology benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Merck KGaA
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Technology benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. QIAGEN
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Technology benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Bio-Rad Laboratories, Inc.
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Technology benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Agilent Technologies, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Technology benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Cube Biotech GmbH
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Technology benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Promega Corporation
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Technology benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Norgen Biotek Corp.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Technology benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Takara Bio. Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Technology benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Danaher
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Technology benchmarking
    • 9.4.10.4. Strategic initiatives

관련자료